Taysha Gene Therapies
TSHA
TSHA
44 hedge funds and large institutions have $13.3M invested in Taysha Gene Therapies in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
70% less capital invested
Capital invested by funds: $43.8M → $13.3M (-$30.5M)
Holders
44
Holding in Top 10
–
Calls
$2K
Puts
$4K
Top Buyers
| 1 | +$114K | |
| 2 | +$72.1K | |
| 3 | +$69K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$67.9K |
| 5 |
Morgan Stanley
New York
|
+$51.2K |
Top Sellers
| 1 | -$1M | |
| 2 | -$811K | |
| 3 | -$252K | |
| 4 |
Renaissance Technologies
New York
|
-$215K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$158K |